Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Go back to Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)| Otter Lake Resources, Inc. New (NASDAQ: OTLK) | Delayed: 1.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $0.03 | |||
| Open | $1.83 | 52 Week Low | $0.01 | |||
| Day High | $1.83 | P/E | N/A | |||
| Day Low | $1.83 | EPS | $0.00 | |||
| Volume | 634,689 | |||||
